Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Bullboard Posts
Post by commoneron Dec 05, 2019 2:18pm
172 Views
Post# 30425965

Another anniversary

Another anniversaryNext week, on December 10, will be two years since Sernova announced the US FDA IND.

On numerous occasions, I have been promised "a waterflood of press releases", "a collaboration with a major pharma", "that 2019 is going to be the year", etc., etc., etc.

The fact is, the only thing they have published lately is a cartoon.

I see that they have hired another CFO.  This is the fifth or sixth CFO since I started buying Sernova.  It is not a good sign.when a company keeps chewing through CFO'S.    And it is really not a good sign that the current CFO is an acquaintance of Mr. Mathews and was recommended by Mr. Mathews.

In my humble opinion, Mr Mathews is overreaching and is in a spot that is self-serving and way beyond his capabilities.

It is a hell of a shame.  Sernova had a great idea, good patents, strong shareholder support, and some fabulous scientists on staff.  What the hell happened?

They will now be passed by their competitors and new science, their patents will expire, they will run out of cash, and Sernova will continue to talk about space shuttles and Egg McMuffins.

I have been invested in this company for a very long time.  The share price is currently 20% below my cost.   I have heard all the excuses, promises, and BS and I have had enough.


Bullboard Posts